Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.
Email alerts

Application overview

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

K A de Macedo R

86 indexed publications match this author name.

ORCID
Not found in stored metadata
OpenAlex
Not found in stored metadata

Author watchlist

Create a confirmed email alert for new publications matching this author.

Publication history

Perceptions and Attitudes on Psilocybin-Assisted Therapy among Underrepresented People with Cancer.Journal of pain and symptom management · 2026-09-18Level of preparedness to use psilocybin among individuals seeking psychedelic risk reduction: a retrospective study of a pilot psychiatric consultation serviceFrontiers in Public Health · 2026-09-16Music Playlist Use in Clinical Trials of Psychedelic Assisted Psychotherapy: A Systematic Review.Journal of clinical psychology · 2026-09-01The Use of Psilocybin for Managing Refractory Behavioral Health Conditions: A Narrative ReviewLynchburg Journal of Medical Science · 2026-08-20Safety and Mental Health Outcomes of Oregon State-Regulated Psilocybin ServicesJAMA Network Open · 2026-08-19Psychedelic integration beyond the verbal: participatory-imaginal processing as a hypothesis-generating therapeutic frameworkFrontiers in Psychiatry · 2026-08-12Psilocybin acutely dissociates cognitive and affective empathy, with empathic concern predicting persisting positive psychological effectsbioRxiv · 2026-08-10Integration in classic psychedelic-assisted therapies for mental health conditions: A scoping reviewPsychedelics · 2026-07-26Silence is golden: Documenting the speech production of participants and support providers in psilocybin administration sessions for the treatment of post-traumatic stress disorderJournal of Psychopharmacology · 2026-07-16Psilocybin therapy for adult females with anorexia nervosa: pilot studyThe British Journal of Psychiatry · 2026-07-08Psychedelics disrupt hierarchical cortical propagations in the default mode network of humans and mice.Proceedings of the National Academy of Sciences of the United States of America · 2026-06-16Global increases in brain glucose metabolism following acute N,N-dimethyltryptamine and harmine administration in healthy volunteers: A randomised [F]FDG-PET study.Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism · 2026-06-01Prevalence and Correlates of Past-Year Psilocybin Use in the U.S., 2024, USAAJPM Focus · 2026-05-01Psilocybin Trends in States That Decriminalized UseJAMA · 2026-04-14An international mega-analysis of psychedelic drug effects on brain circuit function.Nature medicine · 2026-04-01Psilocybin Prolongs the Neurovascular Coupling Response in Mouse Visual Cortex.bioRxiv: the preprint server for biology · 2026-03-25Psilocybin and Ibogaine in Cocaine-Seeking: Extinction Enhancement Without Relapse PreventionAddiction Biology · 2026-03-01Psilocybin-assisted therapy for demoralisation in hospice patients: feasibility, safety and preliminary efficacy.BMJ supportive & palliative care · 2026-02-27Approved and Pipeline Pharmacological Interventions for Eating Disorders (2010-2025): 15 Years of Progress (or Lack Thereof).CNS drugs · 2026-02-01[Pharmacological post-acute treatment of alcohol use disorder: Established strategies and innovative approaches].Therapeutische Umschau. Revue therapeutique · 2026-02-01Correction: Characteristics and mental health of psychedelic mushroom and multi-psychedelic users relative to non-psychedelic users in American adults, 2020-2021.Frontiers in psychiatry · 2026-01-01Psychedelic-Assisted Therapy (Pat): A New Frontier in Mental Health Treatment˜The œjournal of desk research review and analysis. · 2025-12-16Single-dose (10 mg) psilocybin reduces symptoms in adults with obsessive-compulsive disorder: A pharmacological challenge study.Comprehensive psychiatry · 2025-10-01Separate or inseparable? Serotonin and dopamine system interactions may underlie the therapeutic potential of psilocybin for anorexia nervosa.Physiology & behavior · 2025-09-01Separate or inseparable? Serotonin and dopamine system interactions may underlie the therapeutic potential of psilocybin for anorexia nervosaPhysiology & behavior · 2025-09-01Effects of serotonergic psychedelics on synaptogenesis and immediate early genes expression - comparison with ketamine, fluoxetine and lithium.Journal of psychopharmacology (Oxford, England) · 2025-09-01Psychedelic-Assisted Therapy: Potential Benefits and Challenges in Mental Health Treatment.Medical science monitor: international medical journal of experimental and clinical research · 2025-08-09Global Increases in Brain Glucose Metabolism Following Acute N,N-Dimethyltryptamine and Harmine Administration in Healthy Volunteers: An [¹⁸F]FDG-PET StudyResearch Square · 2025-07-27Behavioural and pharmacological evaluation of the psilocybin analogue baeocystin in Wistar rats.Progress in neuro-psychopharmacology & biological psychiatry · 2025-07-13Psilocybin therapy for mood dysfunction in Parkinson's disease: an open-label pilot trial.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2025-07-01Efficacy and safety of psilocybin for the treatment of substance use disorders: A systematic review.Neuroscience and biobehavioral reviews · 2025-06-01Patients' Attitudes Toward Hallucinogenic and Non-Hallucinogenic Psilocybin for Mental Health Treatment.Journal of psychoactive drugs · 2025-05-29ALSUntangled #77: Psilocybin.Amyotrophic lateral sclerosis & frontotemporal degeneration · 2025-05-01Rapid and sustained antidepressant effects of vaporized N,N-dimethyltryptamine: a phase 2a clinical trial in treatment-resistant depression.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2025-05-01Precision Functional Mapping of Psilocybin’s Acute and Persistent Brain EffectsBiological Psychiatry · 2025-04-09A multi-institutional investigation of psilocybin's effects on mouse behavior.bioRxiv: the preprint server for biology · 2025-04-09The compulsive eating paradigm: can psychedelics help in treating obesity?Journal of eating disorders · 2025-04-07The Impact of Communicating the Benefits and Safety of Psilocybin on Policy Support: A Survey Based Experiment.PsyArXiv · 2025-02-25The Impact of Communicating the Benefits and Safety of Psilocybin on Policy Support: A Survey Based Experiment.PsyArXiv · 2025-02-24Psilocybin mushroom stewardship: A qualitative inquiry into practices and priorities of “underground” psilocybin mushroom practitionersJournal of Psychedelic Studies · 2025-02-05Moral Considerations and the Experience of Ego Dissolution: Insights from PsilocybinAsian Journal of Ethics in Health and Medicine · 2025-01-01Study Protocol for 'PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity'.Cureus · 2025-01-01Correction: Study Protocol for 'PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity'.Cureus · 2025-01-01Characteristics and mental health of psychedelic mushroom and multi-psychedelic users relative to non-psychedelic users in American adults, 2020-2021.Frontiers in psychiatry · 2025-01-01Serotonin 5-HT2A receptor expression is chronically decreased in the anterior cerebral cortex of male rats following repetitive low-level blast exposure.Frontiers in neurology · 2025-01-01Therapeutic and legal aspects of psilocybin in cancer-related depression.Frontiers in psychiatry · 2025-01-01Psilocybin-assisted psychotherapy for depression and anxiety associated with life threatening illness: A phase 2b randomized controlled trial.General hospital psychiatry · 2025-01-01Correction: Therapeutic and legal aspects of psilocybin in cancer-related depression.Frontiers in psychiatry · 2025-01-01Exploring the neurobiological correlates of psilocybin-assisted psychotherapy in eating disorders: a review of potential methodologies and implications for the psychedelic study design.Journal of eating disorders · 2024-12-27Effects of serotonergic psychedelics on synaptogenesis and immediate early genes expression - comparison with ketamine, fluoxetine and lithiumbioRxiv · 2024-08-09Developing the Open Psychedelic Evaluation Nexus consensus measures for assessment of supervised psilocybin services: An e-Delphi study.Journal of psychopharmacology (Oxford, England) · 2024-08-01Rapid and prolonged antidepressant and antianxiety effects of psilocybin, lysergic acid diethylamide, ayahuasca, and 3, 4-methylenedioxy-methamphetamine. A systematic review and meta-analysis of randomized controlled trialsmedRxiv · 2024-06-20Developing a Direct Observation Measure of Therapeutic Connection in Psilocybin-Assisted Therapy: A Feasibility Study.Journal of palliative medicine · 2023-12-01Psychedelic Drugs or Hallucinogens: Exploring Their Medicinal Potential.Cureus · 2023-11-01use of psilocybin in the treatment of psychiatric disorders - reviewJournal of Education Health and Sport · 2023-08-15Are psychedelic medicines the reset for chronic pain? Preliminary findings and research needs.Neuropharmacology · 2023-08-01Role of Psychedelics in Treatment-Resistant Depression.The Psychiatric clinics of North America · 2023-06-01Persons With Spinal Cord Injury Report Peripherally Dominant Serotonin-Like Syndrome After Use of Serotonergic Psychedelics.Neurotrauma reports · 2023-01-01Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.The New England journal of medicine · 2022-11-03Psychedelics for Alzheimer's Disease Palliative Care.Advances in psychiatry and behavioral health · 2022-09-01Psychedelic perceptions: mental health service user attitudes to psilocybin therapy.Irish journal of medical science · 2022-06-01Safety issues of psilocybin and LSD as potential rapid acting antidepressants and potential challenges.Expert opinion on drug safety · 2022-06-01Corrigendum: Psychedelic Mushrooms in the USA: Knowledge, Patterns of Use, and Association With Health Outcomes.Frontiers in psychiatry · 2022-01-01Neuroimaging Correlates of Treatment Response with Psychedelics in Major Depressive Disorder: A Systematic Review.Chronic stress (Thousand Oaks, Calif.) · 2022-01-01Use of hallucinogens in Slovakia: Does it differ from global trends?The International journal on drug policy · 2021-12-01Psilocybin-assisted therapy for the treatment of resistant major depressive disorder (PsiDeR): protocol for a randomised, placebo-controlled feasibility trial.BMJ open · 2021-12-01Psilocybin for Depression: The ACE Model ManualPsyArXiv · 2021-07-05Psychedelic resting-state neuroimaging: a review and perspective on balancing replication and novel analysesPsyArXiv · 2021-06-10Stability of psilocybin and its four analogs in the biomass of the psychotropic mushroom Psilocybe cubensis.Drug testing and analysis · 2021-02-01Development and Evaluation of a Therapist Training Program for Psilocybin Therapy for Treatment-Resistant Depression in Clinical Research.Frontiers in psychiatry · 2021-01-01Effects of Ayahuasca on the Recognition of Facial Expressions of Emotions in Naive Healthy Volunteers: A Pilot, Proof-of-Concept, Randomized Controlled Trial.Journal of clinical psychopharmacology · 2021-01-01Cross-Sectional Associations Between Lifetime Use of Psychedelic Drugs and Psychometric Measures During the COVID-19 Confinement: A Transcultural Study.Frontiers in psychiatry · 2021-01-01Effects of Ayahuasca on Personality: Results of Two Randomized, Placebo-Controlled Trials in Healthy Volunteers.Frontiers in psychiatry · 2021-01-01Study Protocol for "Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study".Frontiers in psychiatry · 2021-01-01Psychedelic Mushrooms in the USA: Knowledge, Patterns of Use, and Association With Health Outcomes.Frontiers in psychiatry · 2021-01-01Increased use of illicit drugs in a Dutch cluster headache population.Cephalalgia: an international journal of headache · 2019-04-01PM502. Effect of psilocybin on EEG brain connectivity in healthy volunteers - preliminary reportThe International Journal of Neuropsychopharmacology · 2016-05-26PM506. Psilocybin Clinical Trial: Acute Effects and its relationship to the brain activity as measured by quantitative EEGThe International Journal of Neuropsychopharmacology · 2016-05-26Pholiotina cyanopus, a rare fungus producingpsychoactive tryptaminesOpen Life Sciences · 2014-11-19A survey of hallucinogenic mushroom use, factors related to usage, and perceptions of use among college students.Drug and alcohol dependence · 2013-06-01Unrecognized magic mushroom abuse in a 28-year-old man.The American journal of emergency medicine · 2008-10-01Handling of psilocybin and psilocin by everted sacs of rat jejunum and colon.Acta pharmaceutica Nordica · 1989-01-01Phenomenally phunny phungi--psilocybin toxicity.North Carolina medical journal · 1983-10-01A characteristic effect of hallucinogens on investigatory responding in rats.Psychopharmacology · 1979-09-01[EFFECT OF PSILOCYBIN ON THE CLINICAL AND ELECTROENCEPHALOGRAPHIC PICTURE IN ORGANIC CNS LESIONS].Activitas nervosa superior · 1963-05-01Effects of LSD-25, psiolocybin, and psilocin on temporal lobe EEG patterns and learned behavior in the cat.Neurology · 1962-09-01

Author directory

Robin Carhart-Harris176 publicationsDavid Nutt121 publicationsDavid Erritzøe84 publicationsFranz X. Vollenweider84 publicationsRoland R. Griffiths84 publicationsMatthew W. Johnson70 publicationsKatrin H. Preller64 publicationsFrederick S. Barrett61 publicationsGitte M. Knudsen57 publicationsLeor Roseman55 publicationsJames Rucker48 publicationsAlbert Garcia-Romeu46 publicationsTomáš Páleníček45 publicationsPatrick M. Fisher43 publicationsSandeep M. Nayak43 publicationsJoshua D. Rosenblat42 publicationsDea Siggaard Stenbæk41 publicationsKim P. C. Kuypers41 publicationsNatasha L. Mason38 publicationsPeter S. Hendricks38 publicationsAlan K. Davis36 publicationsDavid Bryce Yaden35 publicationsMatthias E. Liechti34 publicationsMuhammad Ishrat Husain34 publicationsChristopher Timmermann33 publicationsBrice Ozenne32 publicationsJohns Hopkins University31 publicationsGuy M. Goodwin30 publicationsHannes Kettner30 publicationsStephen Ross30 publicationsJohannes G. Ramaekers29 publicationsMichael P. Bogenschutz29 publicationsRoger S. McIntyre29 publicationsDirk Hoffmeister28 publicationsErich Seifritz27 publicationsRobert B. Kargbo27 publicationsRichard J. Zeifman26 publicationsBrian Anderson25 publicationsJavier González-Maeso25 publicationsMartin Korsbak Madsen25 publicationsXiaohui Wang25 publicationsAllan H. Young24 publicationsCharles D. Nichols24 publicationsDrummond E-Wen McCulloch24 publicationsGabrielle Agin-Liebes24 publicationsMartin Kuchař24 publicationsMorten L. Kringelbach24 publicationsNathan D. Sepeda24 publicationsNatalie Gukasyan23 publicationsPaul Liknaitzky23 publicationsFriederike Holze22 publicationsGustavo Deco22 publicationsScott Aaronson22 publicationsBrian S. Barnett21 publicationsBruna Giribaldi21 publicationsJacob S. Aday21 publicationsManoj Doss21 publicationsOlivia Carter21 publicationsOtto Simonsson21 publicationsRafael G. dos Santos21 publicationsAdam L. Halberstadt20 publicationsAlex Kwan20 publicationsJiřı́ Horáček20 publicationsMichael Kometer20 publicationsBenjamin Kelmendi19 publicationsBernard Lerer19 publicationsJaime E. C. Hallak19 publicationsMatthew B. Wall19 publicationsRoland A. Fischer19 publicationsRotem Petranker19 publicationsCharles L. Raison18 publicationsDavid E. Nichols18 publicationsEnzo Tagliazucchi18 publicationsFelix Müller18 publicationsFilip Tylš18 publicationsMendel Kaelen18 publicationsRobert A. Schoevers18 publicationsAlexander M. Sherwood17 publicationsAmanda Feilding17 publicationsChristopher S. Stauffer17 publicationsDavid J. Hellerstein17 publicationsFernando Rosas17 publicationsJeffrey Guss17 publicationsManish Agrawal17 publicationsMilan Scheidegger17 publicationsTomislav Majić17 publicationsWilliam A. Richards17 publicationsClaire J. Foldi16 publicationsJason B. Luoma16 publicationsKevin F. Boehnke16 publicationsLea J. Mertens16 publicationsMalievskaia E16 publicationsNadav Liam Modlin16 publicationsSophia Armand16 publicationsYale University16 publicationsAnna M. Becker15 publicationsCharles S. Grob15 publicationsEmmanuelle A. D. Schindler15 publicationsFelix Hasler15 publicationsGeyer MA15 publicationsJoshua S. Siegel15 publicationsKelly JR15 publicationsLindsey Marwood15 publicationsSuresh Muthukumaraswamy15 publicationsTzuri Lifschytz15 publicationsUniversity Hospital15 publicationsBoadie W. Dunlop14 publicationsBrandon Weiss14 publicationsChristopher Pittenger14 publicationsFederico Seragnoli14 publicationsGerhard Gründer14 publicationsGregor Hasler14 publicationsHenrik Jungaberle14 publicationsJanis Fricke14 publicationsJeng-Yu Tsai14 publicationsJennifer Jones14 publicationsJochen Gartz14 publicationsMeg J Spriggs14 publicationsMika Turkia14 publicationsNathalie M. Rieser14 publications